These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 38885904)

  • 1. "Tinea capitis caused by Microsporum canis: A case study of three family members in India, a non-endemic region.
    Capoor MR; Sharma S; Goenka S; Das S; Rudramurthy SM; Khunger N; Kamra N
    Indian J Med Microbiol; 2024 Jun; 50():100621. PubMed ID: 38885904
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tinea Capitis by Microsporum canis in an Elderly Female with Extensive Dermatophyte Infection.
    Yang Z; Chen W; Wan Z; Song Y; Li R
    Mycopathologia; 2021 May; 186(2):299-305. PubMed ID: 33496917
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systemic antifungal therapy for tinea capitis in children.
    Chen X; Jiang X; Yang M; González U; Lin X; Hua X; Xue S; Zhang M; Bennett C
    Cochrane Database Syst Rev; 2016 May; 2016(5):CD004685. PubMed ID: 27169520
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Microsporum canis infection in three familial cases with tinea capitis and tinea corporis.
    Yin B; Xiao Y; Ran Y; Kang D; Dai Y; Lama J
    Mycopathologia; 2013 Oct; 176(3-4):259-65. PubMed ID: 23918090
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antimicrobial Susceptibility of Tinea Capitis in Children from Egypt.
    Doss RW; El-Rifaie AA; Radi N; El-Sherif AY
    Indian J Dermatol; 2018; 63(2):155-159. PubMed ID: 29692458
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New treatments for tinea capitis.
    Chan YC; Friedlander SF
    Curr Opin Infect Dis; 2004 Apr; 17(2):97-103. PubMed ID: 15021047
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neonatal-Onset Inflammatory Tinea Capitis by Microsporum canis Due to a Woolen Hat.
    Zou X; Chen W; Li R
    Mycopathologia; 2023 Oct; 188(5):585-587. PubMed ID: 36646941
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Three Cases of Recalcitrant Pediatric Tinea Capitis Successfully Treated with Griseofulvin.
    Jung ES; Lee SK; Lee IJ; Nam KH; Yun SK; Kim HU; Park J
    Ann Dermatol; 2023 Nov; 35(Suppl 2):S247-S251. PubMed ID: 38061714
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular typing study of the Microsporum canis strains isolated from an outbreak of tinea capitis in a school.
    Yu J; Wan Z; Chen W; Wang W; Li R
    Mycopathologia; 2004 Jan; 157(1):37-41. PubMed ID: 15008343
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Microsporum canis infections in children: results of a new oral antifungal therapy.
    Ginter G
    Mycoses; 1996; 39(7-8):265-9. PubMed ID: 9009643
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Itraconazole is effective in the treatment of tinea capitis caused by Microsporum canis.
    Gupta AK; Ginter G
    Pediatr Dermatol; 2001; 18(6):519-22. PubMed ID: 11841643
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Coexistence of
    Shi L; Li J; Liu W; Shi D
    Infect Drug Resist; 2024; 17():2431-2438. PubMed ID: 38912215
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Systemic antifungal therapy for tinea capitis in children.
    González U; Seaton T; Bergus G; Jacobson J; Martínez-Monzón C
    Cochrane Database Syst Rev; 2007 Oct; (4):CD004685. PubMed ID: 17943825
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tinea capitis.
    Gupta AK; Summerbell RC
    Med Mycol; 2000 Aug; 38(4):255-87. PubMed ID: 10975696
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Microsporum canis tinea capitis in an 8-month-old infant successfully treated with 2 weekly pulses of oral itraconazole.
    Koumantaki E; Georgala S; Rallis E; Papadavid E
    Pediatr Dermatol; 2001; 18(1):60-2. PubMed ID: 11207976
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tinea capitis dermatophytes: susceptibility to antifungal drugs tested in vitro and in vivo.
    Mock M; Monod M; Baudraz-Rosselet F; Panizzon RG
    Dermatology; 1998; 197(4):361-7. PubMed ID: 9873175
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tinea Capitis: An Updated Review.
    Leung AKC; Hon KL; Leong KF; Barankin B; Lam JM
    Recent Pat Inflamm Allergy Drug Discov; 2020; 14(1):58-68. PubMed ID: 31906842
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Microsporum canis-Induced Tinea Capitis: A Rapid Screening Algorithm.
    Martínez-Ortega JI; Franco González S; Martinez-Jaramillo B; Ramirez Cibrian AG
    Cureus; 2024 Mar; 16(3):e55919. PubMed ID: 38601420
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro pharmacodynamic characteristics of griseofulvin against dermatophyte isolates of Trichophyton tonsurans from tinea capitis patients.
    Gupta AK; Williams JV; Zaman M; Singh J
    Med Mycol; 2009 Dec; 47(8):796-801. PubMed ID: 19212895
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A randomized, double-blind, parallel-group, duration-finding study of oral terbinafine and open-label, high-dose griseofulvin in children with tinea capitis due to Microsporum species.
    Lipozencic J; Skerlev M; Orofino-Costa R; Zaitz VC; Horvath A; Chouela E; Romero G; Gourmala N; Paul C;
    Br J Dermatol; 2002 May; 146(5):816-23. PubMed ID: 12000378
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.